Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health Corp    CVS

Delayed Quote. Delayed  - 02/10 04:01:21 pm
93.11 USD   +2.87%
02/10 CVS HEALTH : Offering Meningitis Vaccines to Residents in Santa Clar..
02/10 CVS HEALTH : Accordant Earns NCQA Accreditation for Case Management
02/10DJCVS Gets Boost From Prescription-Drug Sales
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

CVS Caremark 4th-Quarter Profit Rose 2.6% Amid Continued Sales Growth

02/06/2013 | 07:52am US/Eastern
   By Tess Stynes 
 

CVS Caremark Corp.'s (>> CVS Caremark Corporation) fourth-quarter earnings rose 2.6% as the company reported revenue growth in its pharmacy-services and retail drugstore operations.

For the year, the company raised its forecast for per-share adjusted earnings from continuing operations by two cents and now expects $3.86 to $4.

CVS's retail pharmacy business gained customers last year in the wake of a contract dispute between rival Walgreen Co.'s (>> Walgreen Company) and pharmacy-benefits manager Express Scripts Holding Co. (>> Express Scripts Holding Co) that has since been resolved.

A wave of major generic drugs introductions is having a mixed effect on the industry. Though the copycat drugs carry higher margins than branded products, they command lower prices, hurting sales revenue.

CVS Caremark reported a profit of $1.13 billion, or 90 cents a share, up from $1.1 billion, or 81 cents a share, a year earlier. Excluding debt-extinguishment losses, acquisition-related charges and other items, adjusted earnings from continuing operations were $1.14. Revenue increased 11% to $31.39 billion.

Analysts polled by Thomson Reuters most recently projected earnings of $1.10 on revenue of $31.13 billion.

Revenue in the larger pharmacy-services business climbed 17% to $18.6 billion, reflecting new client starts, higher prices and growth of its Medicare Part D program. Pharmacy network claims processed rose 6.5%.

On the retail side, revenue increased 5.1% to $16.3 billion. Same-store sales were up 4% from a year earlier, as pharmacy same-store sales also improved by 4%. Same-store sales in the front end of the store grew 3.9%.

Shares closed Tuesday at $51.72 and were inactive premarket.

Write to Tess Stynes at tess.stynes@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

React to this article
Latest news on CVS HEALTH CORP
02/10 CVS HEALTH : Offering Meningitis Vaccines to Residents in Santa Clara County, CA
02/10 CVS HEALTH : Accordant Earns NCQA Accreditation for Case Management
02/10DJCVS Gets Boost From Prescription-Drug Sales
02/09 CVS HEALTH : MinuteClinic Marks Decade of Accreditation from The Joint Commissio..
02/09 CVS HEALTH : Research Institute Study Shows 11.4 Percentage Point Improvement in..
02/09DJMARKET SNAPSHOT : U.S. Stocks End Flat After Seesaw Session Amid Oil Slide
02/09DJMARKET SNAPSHOT : U.S. Stocks End Flat After Seesaw Session Amid Oil Slide
02/09DJMARKET SNAPSHOT : U.S. Stocks Turn Positive As Materials, Health Care Shares Ral..
02/09 CVS HEALTH : Families First receives $10K grant
02/09DJMARKET SNAPSHOT : U.S. Stocks Retreat, Led By Energy Sector, As Oil Tumbles Agai..
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials